14. How do you determine which treatment should be used, and for how long?
|
When I try to look at it objectively, the
first thing you have to do is weigh the side effects - interferon has
more side effects, and lamivudine and adefovir are very
patient-friendly. There are three prognostic markers for
treatment with interferon: viral load (those with a lower load usually
respond better), ALTs (those with higher levels usually respond
better), and duration of the infection (those with shorter duration
have a better response, usually). Most Asian patients do not meet these
prognostic indicators for treatment with Interferon. Once again, I look at hepatitis from an
infectious disease point of view - it is a chronic infection, and
might need chronic suppression (long-term) just like HIV or
diabetes.
|
|
|
13. Should the e-antigen be used to determine the success/end point of treatment?
|
15. Do you recommend treating patients with a high-viral load and normal ALTs (liver enzyme levels)?
|
|